Parallax Volatility Advisers, L.P. Biogen Inc. Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Biogen Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 14,266 shares of BIIB stock, worth $2.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,266

Holding current value

$2.48 Million

% of portfolio

0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $2.72 Million - $3.38 Million	14,266 New	14,266 $3.31 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $2.5 Million - $2.82 Million	9,864 Added 66.15%	24,775 $6.37 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $4.1 Million - $4.74 Million	14,911 New	14,911 $4.25 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $33.2 Million - $41.8 Million	-171,220 Reduced 88.19%	22,926 $4.83 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $26.4 Million - $34 Million	118,088 Added 155.26%	194,146 $46.6 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $17.8 Million - $23.2 Million	62,823 Added 474.67%	76,058 $21.5 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $3.37 Million - $5.39 Million	12,993 Added 5369.01%	13,235 $4.58 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $337,214 - $395,066	-1,388 Reduced 85.15%	242 $68,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $3.3 Million - $4.96 Million	-13,954 Reduced 89.54%	1,630 $399,000
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $810,725 - $936,084	-3,062 Reduced 16.42%	15,584 $4.42 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $2.91 Million - $3.85 Million	11,239 Added 151.73%	18,646 $4.99 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $1.45 Million - $1.84 Million	5,389 Added 267.05%	7,407 $2.34 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $5.12 Million - $7.07 Million	-23,259 Reduced 92.02%	2,018 $599,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $5.16 Million - $5.79 Million	23,747 Added 1552.09%	25,277 $5.88 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $265,340 - $292,481	-1,210 Reduced 44.16%	1,530 $358,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $2.51 Million - $3.93 Million	-11,582 Reduced 80.87%	2,740 $648,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $1.43 Million - $1.81 Million	5,122 Added 55.67%	14,322 $4.31 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $1.79 Million - $2.34 Million	6,088 Added 195.63%	9,200 $3.25 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $1.12 Million - $1.34 Million	-4,351 Reduced 58.3%	3,112 $903,000
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $1.63 Million - $2.31 Million	-6,277 Reduced 45.68%	7,463 $2.04 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $2.06 Million - $2.3 Million	6,680 Added 94.62%	13,740 $4.38 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $1.98 Million - $2.33 Million	7,060	7,060 $2.21 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Biogen Inc. Transaction History